Birchview Capital’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.16M Hold
286,804
2.37% 11
2025
Q4
$1.95M Hold
286,804
1.14% 24
2025
Q3
$2.17M Sell
286,804
-2
-0% -$15 1.63% 15
2025
Q2
$1.62M Hold
286,806
1.61% 18
2025
Q1
$3.59M Hold
286,806
3.11% 5
2024
Q4
$8.78M Buy
286,806
+2,000
+0.7% +$58.8K 7.14% 2
2024
Q3
$10.1M Hold
284,806
8.77% 2
2024
Q2
$8.7M Buy
284,806
+17,392
+7% +$497K 8.04% 2
2024
Q1
$7.63M Hold
267,414
6.22% 3
2023
Q4
$9.79M Hold
267,414
7.66% 3
2023
Q3
$8.74M Buy
267,414
+15,432
+6% +$428K 7.43% 2
2023
Q2
$6.2M Hold
251,982
4.65% 4
2023
Q1
$9.37M Hold
251,982
7.34% 2
2022
Q4
$11.6M Buy
251,982
+133,478
+113% +$3.63M 8.19% 2
2022
Q3
$3.01M Buy
118,504
+27,933
+31% +$1.08M 2.12% 10
2022
Q2
$2.93M Buy
90,571
+27,933
+45% +$908K 2.13% 9
2022
Q1
$2.12M Hold
62,638
1.52% 12
2021
Q4
$6.63M Buy
62,638
+7,390
+13% +$965K 4.27% 7
2021
Q3
$9.08M Hold
55,248
6.18% 3
2021
Q2
$14.6M Hold
55,248
8.73% 3
2021
Q1
$22.4M Sell
55,248
-6
-0% -$2.68K 13.32% 2
2020
Q4
$22.3M Buy
+55,254
New +$17.2M 12.83% 2

Other funds holding BDSX

Birchview Capital's BDSX Position: Q1 2026 in Review

Birchview Capital held its Biodesix (BDSX) position steady in Q1 2026 at 286,804 shares worth $4.16M. The position accounts for 2.37% of the portfolio, ranked #11.

Birchview Capital first reported a position in BDSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $22.4M in Q1 2021. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Birchview Capital held 286,804 shares of Biodesix worth $4.16M as of Q1 2026.
  • Birchview Capital left its Biodesix share count unchanged in Q1 2026.
  • Biodesix made up 2.37% of Birchview Capital's portfolio in Q1 2026, its #11 holding.
  • Birchview Capital first reported a position in Biodesix in Q4 2020 and has held it in 22 quarters since.
  • Birchview Capital's Biodesix position peaked at $22.4M in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Birchview Capital's 13F filing for Q1 2026, filed 15 May 2026.